News

Croom Lawrence Joins Hemostemix With Revenue Share Agreement And Vescell.Health Launch
Hemostemix and Acurist (Croom Lawrence) have agreed to share revenue from each cognitive assessment such that 57% of revenue is allocated to Acurist and 43% of revenue is allocated to Hemostemix from ...
Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces its Chairman, Peter Lacey, ...
Novel PET imaging approach detects heart damage in patients with non-ischemic cardiomyopathy
A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...